49 Effects of GLP-1 RAs on Quality of Life In addition to reducing the risk of hospital admission and mortality, improving health-related quality of life (HRQoL) is another treatment target in HF
DOI: 10.1002/mnfr.202100071 Liu, D., Alkhalidy, H., et al
The above results suggest that terpenoids can reduce the excessive buildup of the extracellular matrix in the kidney, alleviate renal fibrosis, and diminish apoptosis
Up to 20% off | CODE: PLUS15 Superset Nutrition Supporting healthy fat metabolism
Sanchez-Macedo, N
)
[1] [2] GLP-1 medications work through several complementary mechanisms: Enhancing insulin secretion : They stimulate the pancreas to release insulin when blood glucose levels are elevated, helping to lower blood sugar in a glucose-dependent manner Suppressing glucagon release : They reduce the secretion of glucagon, a hormone that raises blood glucose, thereby preventing excessive glucose production by the liver Slowing gastric emptying : They delay the rate at which food leaves the stomach, leading to more gradual glucose absorption and increased feelings of fullness Reducing appetite : They act on areas of the brain involved in appetite regulation, helping to decrease food intake [2] [22] Commonly prescribed GLP-1 receptor agonists in the UK include semaglutide (Ozempic for diabetes, Wegovy for weight management, Rybelsus as an oral formulation), dulaglutide (Trulicity), liraglutide (Victoza for diabetes, Saxenda for weight management), and exenatide (Byetta, Bydureon)
